Snowflake Inc SEC Filings

Snowflake Inc. (SNOW) – Form 4 insider transaction

President of Products and Director Benoit Dageville reported an option exercise and coincident share sale on 06/30/2025:

• Option exercise (Code M): 25,000 Class A shares acquired at an exercise price of $0.74, costing roughly $18.5 k.
• Open-market sale (Code S): 25,000 Class A shares sold at an average price of $224.84, generating about $5.6 m gross proceeds.
• Direct ownership decreased to 58,325 shares from 83,325 after the paired transactions.
• The option exercised was fully vested and expires 02/07/2027; 419,863 options remain outstanding.

The trades were executed under a 10b5-1 trading plan adopted on 03/28/2025, providing pre-arranged execution and reducing the likelihood of information-based timing concerns.

Dageville continues to have large indirect stakes held in several trusts—two GRATs of 750,000 shares each and the Snow Trust holding 3,191,555 shares—although he disclaims beneficial ownership of one GRAT.

While the $5.6 m sale is relatively small versus total indirect holdings (~4.7 m shares) and was plan-driven, it trims direct exposure by roughly 30% and can be interpreted by some investors as modestly negative insider sentiment. No company-level financials or operational updates are contained in this filing.

Ryerson Holding Corporation (RYI) director Court D. Carruthers filed a Form 4 disclosing receipt of 405 shares of Ryerson common stock on 30 June 2025. The shares were granted under the company’s Director Compensation Program, vested in full on the grant date and carry a stated price of $0, confirming they are a non-cash equity award rather than an open-market purchase.

After the grant, Carruthers’ direct beneficial ownership increases to 4,958 shares. No derivative securities, dispositions, or additional transactions were reported. The award size is immaterial relative to Ryerson’s share count and therefore unlikely to influence valuation or trading dynamics. Nevertheless, incremental share accumulation marginally aligns the director’s interests with those of shareholders.

Centene Corporation (CNC) – Form 4 insider filing

Director Kenneth A. Burdick reported a modest open-market acquisition of 556 Centene common shares on 30 June 2025 (transaction code A). The shares were acquired at a stated price of $0.00, suggesting the issuance relates to compensation or dividend reinvestment rather than a cash purchase. Following the transaction, Burdick’s direct ownership increases to 367,052.924 shares. He also reports 86,498 indirect shares held through Burdick Family LLC, bringing his aggregated economic interest to roughly 453.6 thousand shares.

The filing also discloses an existing stock option for 10,000 shares with a strike price of $80.57, exercisable from 7 Feb 2025 and expiring 7 Feb 2032. No new derivative transactions were recorded.

While insider purchases are generally viewed as a confidence signal, the 556-share addition represents less than 0.2 % of Burdick’s current stake and is immaterial to Centene’s overall float. The transaction therefore carries limited fundamental impact but modestly reinforces management–shareholder alignment.

Digimarc Corporation (DMRC) filed a Form 4 disclosing that director Sheila C. Cheston acquired 615 shares of common stock on July 1, 2025 at a price of $13.21 per share. Following the purchase, her direct holdings stand at 19,245 shares. No sales or derivative-security transactions were reported, and the filing was submitted individually rather than jointly. While the dollar value of the transaction is modest (about $8,100), the filing demonstrates incremental insider buying and maintains the director’s equity alignment with shareholders.

Form 4 filing overview: Director and 10% owner Gary E. Strahan reported two open-market sales of MultiSensor AI Holdings (MSAI) common stock.

• June 20 2025: Sold 21,470 shares at a weighted-average price of $0.6629 (range $0.6500-$0.6950).
• June 23 2025: Sold 76,711 shares at a weighted-average price of $0.5514 (range $0.5326-$0.6014).

Following the transactions, Strahan directly owns 5,875,907 shares and indirectly owns 305,079 shares through the Jill A. Blashek Revocable Trust, for a total beneficial ownership of roughly 6.18 million shares.

The sales represent approximately 1.6 % of his combined direct and indirect holdings, leaving his ownership status as a 10% beneficial owner intact. No derivative securities were reported.

Snowflake Inc. (SNOW) – Form 144 filing: The notice discloses a planned sale of 10,000 Class A shares on or about 1 July 2025 through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $2.19 million. The filing lists 333.7 million Class A shares outstanding, so the proposed sale represents roughly 0.003% of shares outstanding.

Recent insider activity:

• Over the past three months, Christian Kleinerman and related entity Kleinerman 2020 Dynasty LLC have already disposed of 46,133 shares in eight transactions, generating ≈$9.3 million in gross proceeds.
• Individual transactions ranged from 548 to 10,000 shares, with sale prices implied between $206–$214 per share (based on disclosed proceeds).

Under Rule 144, the filer asserts no possession of undisclosed material adverse information. No earnings, operational updates or other corporate events are included; the document is strictly a compliance notice of intended insider sales.

MetLife, Inc. (MET) filed a Form 144 announcing a proposed sale of 547 shares of common stock through Barclays Capital on 20 June 2025. The aggregate market value of the proposed sale is $42,966.85, compared with 671,297,826 shares currently outstanding, representing roughly 0.00008 % of shares outstanding.

The filing lists prior sales over the past three months by various MetLife-related accounts totaling 686 shares and gross proceeds of about $55,392. Acquisition details show the shares were originally purchased in 2013-2014 from Deutsche Bank for cash. No adverse undisclosed information is attested by the filer, and the signature section affirms compliance with Rule 144 and Rule 10b5-1 provisions.

Given the small size of the transaction relative to MetLife’s market capitalization and float, the notice is largely administrative and unlikely to affect the company’s financial condition or share price.

Cardinal Health, Inc. (CAH) filed a Form 4 indicating that Chief Executive Officer Jason M. Hollar had 5,821 common shares automatically withheld on 06/30/2025 to cover tax obligations arising from the deferred settlement of previously awarded performance share units (transaction code “F”). The price recorded for the withholding was $167.18 per share, representing an aggregate value of roughly $0.97 million. After the transaction, Hollar’s direct ownership stands at 191,815 shares.

This is an administrative, non-open-market transaction. No shares were purchased or sold for investment purposes, and there is no indication of a change in the CEO’s long-term stake. The filing therefore carries minimal fundamental or market impact, serving primarily to update compliance records under Section 16(a).

Form 4 Overview: Maravai LifeSciences Holdings, Inc. (MRVI) disclosed that director John A. DeFord acquired 89,139 shares of Class A common stock on 16 June 2025.

Transaction details: The shares were granted as restricted stock units (RSUs) under the company’s 2020 Omnibus Incentive Plan at an assigned value of $2.16 per share. These RSUs will vest in full on the earlier of (i) one year from the grant date or (ii) the date of the 2026 annual shareholder meeting.

Post-transaction ownership: Following the award, DeFord’s beneficial ownership rises to 159,185 shares, all held directly.

Implications: A director increasing his stake—albeit via equity compensation—tends to align management and shareholder interests and can be interpreted as a vote of confidence in MRVI’s long-term prospects. Because the grant stems from an incentive plan rather than an open-market purchase, any cash outlay by the insider is not indicated in the filing.